19Nov/13

Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure – 4-traders (press release)


Science Codex

Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure
4-traders (press release)
The researchers reported that a single injection into the native heart of 25 million allogeneic, or “off-the-shelf”, MPCs resulted in an improvement in cardiac function at the pre-specified key efficacy endpoint of 90 days, as measured by the ability
Heart failure patients receiving LVAD may benefit from injection of powerful News-Medical.net
Mesoblast MPCs improve function in heart failureAustralian Life Scientist
Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With MarketWatch
irasia.com (press release)
all 19 news articles »
19Nov/13

End-Stage Heart Failure Patients Benefit from Injection of Millions of … – Science Daily (press release)


Science Codex

End-Stage Heart Failure Patients Benefit from Injection of Millions of
Science Daily (press release)
18, 2013 — A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left
Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure4-traders (press release)
Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With GlobeNewswire (press release)

all 19 news articles »